Scientists at The University of Manchester have discovered a genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs.
The study, published in Nature Communications could allow doctors to screen patients at risk from Aspergillus, and could easily be developed into a test.
When breathed in, Aspergillus can be life threatening and also make asthma much worse, especially in people with compromised immune systems. It is found in soil, pillows and compost but is capable of living anywhere in a moist environment, so breathing it in is unavoidable .
Aspergillus is normally cleared from the lungs but 4% of people have this newly discovered mutation and in them, Aspergillus thrives in the airways.
“People with asthma, who have had transplant surgery, TB and many other illnesses that lower immunity could feasibly be screened for this genetic mutation. And early detection could save lives,” said Dr Paul Bowyer who led the study funded by the Fungal infection Trust and supported by the NIHR Manchester Biomedical Research Centre.
People with asthma, who have had transplant surgery, TB and many other illnesses that lower immunity could feasibly be screened for this genetic mutation. And early detection could save lives
Dr Paul Bowyer
Dr Sara Gago discovered the increased risk by comparing normal human cells to cells which had been gene edited to contain the mutation. The gene – known as ZNF77 – is mainly responsible for the extracellular matrix of the lungs’ epithelial tissue- the membrane that protects them. These mutated cells had a weak response to Aspergillus showing how key epithelial cells are to normal defences against this airborne fungus.
Dr Bowyer said: “Until now we never really understood why some people have a much higher Aspergillus load than others. Now that we do, it’s quite a significant advance in understanding this disease. We don’t yet know how or why the mutation occurs but nevertheless this discovery provides the basis for a simple and inexpensive DNA test in those who people who are more at risk from Aspergillus.”
Dr Gago is a Research Fellow funded by the National Centre for the Replacement, Reduction and Refinement of animals in research. She added: “ZNF77 doesn’t actually occur in mice, so the only viable animal models besides humans are primates. Having developed a way to adapt human cell lines so that they can carry mutations associated with disease, we have avoided using primates or any animals entirely.”
Receive an email update when we add a new ASPERGILLUS article.
The Latest on: Aspergillus
via Google News
The Latest on: Aspergillus
- Safety evaluation of the food enzyme glucan 1,4‐α‐glucosidase from a genetically modified Aspergillus niger (strain NZYM‐BW) on October 31, 2018 at 11:48 am
The food enzyme glucan 1,4‐α‐glucosidase (EC 18.104.22.168) is produced with the genetically modified Aspergillus niger strain NZYM‐BW by Novozymes A/S. The genetic modifications do not give rise to safety ... […]
- Genetic profile for a section of Aspergillus fungi on October 22, 2018 at 12:47 pm
Aspergillus is an important fungal genus, with roles in agriculture, biotechnology, human health, enzyme production and food fermentation. Scientists now present the first large analysis of an Aspergi... […]
- Plastic-eating mushrooms are the new superheroes in combating the growing waste crisis on September 26, 2018 at 8:30 am
The aspergillus tubingensis fungus was featured in the State of the World’s Fungi 2018 report, which also documented that fungi are optimal in producing sustainable building materials and capable of r... […]
- Assessment of insect nfestation in stored maize and their relationship to aspergillus flavus contamination on May 17, 2018 at 5:00 pm
An entomological assessment of Thai maize in storage was conducted in relation to Aspergillus flavus infection, aflatoxin contamination and association of stored - product insects. The pattern of inse... […]
- SCYNEXIS Data Presentations at ECCMID 2018 Show SCY-078 Potent and Synergistic Antifungal Activity Against Aspergillus and Pneumocystis on April 22, 2018 at 5:00 pm
Clinical efficacy against Aspergillus strains to be tested in Phase 2 trial to begin in third quarter of 2018 Antifungal activity against Pneumocystis supports potential use for prophylaxis indication... […]
- Comparative analysis of Aspergillus species provides genus-wide view of fungal diversity on February 28, 2017 at 4:53 am
In the world of fungi, Aspergillus is an industrial superstar. Aspergillus niger, for example, has been used for decades to produce citric acid—a compound frequently added to foods and pharmaceuticals ... […]
- Rapid adaptation of Aspergillus fungus presents doctors with a dilemma on September 26, 2016 at 8:48 am
The fungus Aspergillus fumigatus is capable of rapid genetic adaptation in both natural environments and in humans according to a study published in The Lancet Infectious Diseases by Radboud universit... […]
via Bing News